These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18297448)

  • 1. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
    Shigehara K; Miyagi T; Nakashima T; Shimamura M
    J Infect Chemother; 2008 Feb; 14(1):40-3. PubMed ID: 18297448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
    Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A
    J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.
    Mosharafa AA; Torky MH; El Said WM; Meshref A
    Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
    Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M
    Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
    Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M
    Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
    Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
    Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    Ekici S; Cengiz M; Turan G; Alış EE
    Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?
    Kim JW; Oh MM; Bae JH; Kang SH; Park HS; Moon du G
    J Infect Chemother; 2015 Jun; 21(6):434-7. PubMed ID: 25701308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
    Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
    PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases.
    Balaban M; Ozkaptan O; Sevinc C; Boz MY; Horuz R; Kafkasli A; Canguven O
    Int Braz J Urol; 2020; 46(1):60-66. PubMed ID: 31851459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy.
    Miyazaki Y; Akamatsu S; Kanamaru S; Kamiyama Y; Sengiku A; Iguchi R; Sano T; Takahashi A; Ito M; Takenawa J; Ito N; Ogura K
    Urol J; 2016 Mar; 13(1):2533-40. PubMed ID: 26945658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporins periprostatic injection: are really effective on infections following prostate biopsy?
    Pace G; Carmignani L; Marenghi C; Mombelli G; Bozzini G
    Int Urol Nephrol; 2012 Aug; 44(4):1065-70. PubMed ID: 22434340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of levofloxacin-based prophylaxis regimens for transrectal prostate biopsy: a prospective randomized single-center study.
    Su R; Wang KY; Zhang D; Yan ZJ; Jiang JH; Ma Q
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):967-971. PubMed ID: 30919151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
    Oh MM; Chae JY; Kim JW; Kim JW; Yoon CY; Park MG; Moon du G
    Urology; 2013 Jun; 81(6):1209-12. PubMed ID: 23601450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.